Sionna Therapeutics, Inc. SION
- SION-451 — Cystic Fibrosis Phase 1
- galicaftor — Cystic Fibrosis Phase 1
- SION-109 — Cystic Fibrosis Phase 1
- SION-2851 — Cystic Fibrosis Phase 1
- SION-3067 — Cystic Fibrosis Phase 2
CFTR (3 companies · 10 programs)
Companies with an active program directed at CFTR.
Vanda Pharmaceuticals Inc. VNDA
- VSJ-110 — Dry Eye Disease Phase 1
- VPO-227 — Cholera Phase 1
- VSJ-110 — Ocular Inflammation
- VPO-227 — Secretory Diarrhea
4D Molecular Therapeutics, Inc. FDMT
- 4D-710 — Cystic Fibrosis Phase 2